Technetium Tc 99m tilmanocept

锝TC-99M替马诺塞

Report date: 2026/04/27 20:02:09

Base Information

Drug NameTechnetium Tc 99m tilmanocept
Drug Alias NameTc 99m-diethylenetriamine pentaacetic acid mannosyl dextranTechnetium (99mTc) tilmanocept[99mTc]DTPA-mannosyl-dextran[99mTc]Tilmanocepttechnetium Tc-99m tilmanocept +[10] 
ClassificationDiagnostic agent (In vivo)Small moleculesRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionMacrophage mannose receptor 1 modulators
TargetsMacrophage mannose receptor 1
Therapy Area/IndicationsDiagnostic agentsSolid tumoursSarcoidosis +[20] 
Global Approved IndicationsDiagnostic agentsSolid tumoursHead and Neck Neoplasms +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/03/13
Country/TerritoryUnited StatesUnited KingdomIsrael +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A

Develop Information

Active CompaniesNavidea Biopharmaceuticals IncDuke UniversityJubilant Life Sciences Ltd +[4] 
Inactive CompaniesNavidea BiopharmaceuticalsWashington University School Of MedicineStanford University +[7] 
Active IndicationsDiagnostic agentsSolid tumoursSarcoidosis +[8] 
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseArthritis, RheumatoidUterine Cervical Neoplasms +[12] 

Other Information

ATC CodeV09IA09
Related LinksWikipediaDrugBank